XBP Europe Holdings, Inc. Completes $48 Million Financing to Fund Growth
June 27, 2024 13:45 ET
|
XBP Europe
Transaction Refinances Existing Indebtedness and Secures Incremental Liquidity to Fund Growth Financing includes $30 million committed and $18 million accordion feature LONDON, United Kingdom...
UPDATE: Duos Featured on WJXT Channel 4
June 27, 2024 12:57 ET
|
Duos Technologies Group, Inc
UPDATED: Duos Featured on WJXT Channel 4 | https://www.youtube.com/watch?v=DfjBoRHhaqc
Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
June 27, 2024 12:30 ET
|
Denali Capital Acquisition Corp.
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ: DECA) ("Denali" or the "Company") announced today that Denali and Longevity Biomedical, Inc. have mutually...
authID Announces Closing of $11,000,000 Million Registered Direct Offering
June 27, 2024 12:15 ET
|
authID Inc.
DENVER, June 27, 2024 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of innovative biometric identity verification and authentication solutions,...
HashiCorp 2024 State of Cloud Strategy Survey shows the path to cloud success requires platform engineering capabilities
June 27, 2024 12:00 ET
|
HashiCorp, Inc.
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- HashiCorp, Inc. (NASDAQ: HCP), The Infrastructure Cloud™ company, today released its 2024 State of Cloud Strategy Survey. As organizations continue...
PHAXIAM Therapeutics annonce le succès de son augmentation de capital avec maintien du droit préférentiel de souscription de 7,8 M€
June 27, 2024 11:45 ET
|
Phaxiam Therapeutics S.A.
Lyon (France), le 27 juin 2024 - 17h45 CEST - PHAXIAM Therapeutics (la « Société »), société biopharmaceutique qui développe des traitements innovants contre les infections bactériennes sévères et...
Micron Releases 2024 Sustainability Report Highlighting Progress and Long-Term Vision
June 27, 2024 11:00 ET
|
Micron Technology, Inc.
BOISE, Idaho, June 27, 2024 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), a global leader in innovative memory and storage solutions, today announced the release of its 2024...
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron JN.1 angepassten COVID-19-Impfstoff in der Europäischen Union
June 27, 2024 10:30 ET
|
BioNTech SE
Der aktualisierte COVID-19-Impfstoff ist auf die Omikron JN.1-Sublinie von SARS-CoV-2 zugeschnitten und wird für Personen ab 6 Monaten empfohlenDie Beurteilung basiert auf präklinischen und...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
June 27, 2024 10:30 ET
|
BioNTech SE
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and olderRecommendation is based on pre-clinical and...
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
June 27, 2024 09:41 ET
|
Science 37, Inc.
Nearly 20 studies have successfully leveraged Science 37's medical and operational expertise to boost patient recruitment and enrollment activities.